Orgad Laub
Algemeen Directeur bij Sealantium Medical Ltd.
Profiel
Orgad Laub is the founder and Chief Executive Officer of Sealantium Medical Ltd.
which is founded in 2011.
He is currently a Director at Rimonyx Pharmaceuticals Ltd.
Dr. Laub has also worked as a Director at Serono Corp.
and as a Professor at Weizmann Institute of Science.
Actieve functies van Orgad Laub
| Bedrijven | Functie | Begin |
|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Directeur/Bestuurslid | - |
Sealantium Medical Ltd.
 Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Algemeen Directeur | 01-01-2011 |
Eerdere bekende functies van Orgad Laub
| Bedrijven | Functie | Einde |
|---|---|---|
| Serono Corp. | Directeur/Bestuurslid | - |
| Weizmann Institute of Science | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Rimonyx Pharmaceuticals Ltd.
Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
| Serono Corp. | |
Sealantium Medical Ltd.
Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Health Technology |
